Read more at MarketWatch.
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Date: |
-
CNBC - Business
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.26 minutes ago -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.3 hours ago -
CBS News - Top stories
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.1 hour ago -
Financial Times - Business
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high3 hours ago -
The New York Times - Health
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.4 hours ago -
The New York Times - Top stories
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.1 hour ago -
NBC News - Top stories
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.2 hours ago -
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.10 hours ago -
ABC News - Health
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients38 minutes ago
More from MarketWatch
-
MarketWatch - Business
The fan who caught Shohei Ohtani’s 50th home-run ball could make $500,000
Aaron Judge’s 62nd home-run ball in 2022 sold for $1.5 million at auction5 minutes ago -
MarketWatch - Business
Oil prices log weekly gains after Fed rate cut, rising Middle East tensions
Oil futures booked solid weekly gains, boosted by the Federal Reserve’s large interest-rate cut and a renewed rise in tensions in the Middle East.12 minutes ago - Federal Reserve -
MarketWatch - Business
The Fed rate cut scared me. Where should I invest my $127,000 in savings now?
This reader wonders whether CD rates, high-yield savings accounts and bond ladders are still smart moves, even if interest rates keep dropping.15 minutes ago - Federal Reserve -
MarketWatch - Business
Uranium ETFs rally amid plans to revive nuclear reactor in Microsoft agreement
Constellation Energy said Friday it plans to restart a nuclear reactor at Three Mile Island.19 minutes ago - Microsoft -
MarketWatch - Business
10-, 30-year Treasury yields end near 2-week highs amid optimism on U.S. economy
Long-term yields on U.S. government debt finished little changed on Friday, but remained near two-week highs following better news on the U.S. economy from the previous session.24 minutes ago